Frontiers in Oncology (Oct 2015)

Successes and challenges of PARP inhibitors in cancer therapy

Tiffany K Ricks,
Haw-Jyh eChiu,
Gwynn eIson,
Geoffrey eKim,
Amy E McKee,
Paul eKluetz,
Richard ePazdur

Affiliations

Tiffany K Ricks: US Food and Drug Administration
Haw-Jyh eChiu: US Food and Drug Administration
Gwynn eIson: US Food and Drug Administration
Geoffrey eKim: US Food and Drug Administration
Amy E McKee: US Food and Drug Administration
Paul eKluetz: US Food and Drug Administration
Richard ePazdur: US Food and Drug Administration

DOI: https://doi.org/10.3389/fonc.2015.00222
Journal volume & issue: Vol. 5

Abstract

No abstracts available.

Published in Frontiers in Oncology

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/

About the journal